Sullivan previously served as president and CEO of medical device global contract manufacturer Spectrum Plastics. He has also held numerous leadership roles at A&E Medical, Symmetry Surgical and Symmetry Medical. In addition, he held executive positions at Johnson & Johnson, including president of J&J’s medical products Canada division and its U.S. orthopedics division.
Natus Medical provides medical equipment, software, supplies, and services to diagnose, monitor, and treat impairments and disorders affecting newborns, the brain, nerves, muscles, balance, mobility, and hearing.
The company’s board chair Joshua Levine described Sullivan as a proven business leader with a long track record of creating shareholder value. “As a Natus independent director these past three years, he has shown his strategic insight and drive for Natus’ potential for market leadership through holistic business model execution,” Levine said in a news release.
Levine also thanks Jonathan Kennedy, who resigned as CEO on December 13, for “successfully positioning the company for its next phase of innovation and growth.”
Sullivan said he was humbled by the opportunity to lead Natus. “Together we will build upon the Natus heritage of innovation and market leadership to drive growth while advancing the standard of care for healthcare professionals in the diagnosis, monitoring, and treatment of impairments of the central nervous and sensory systems.”